Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 201

Sort by

Sort Order Select

Journal Articles

Polyunsaturated fatty acids control lipid membrane dynamics and ferroptosis sensitivity in B-cell lymphoma

Etienne Leveille, Eden Bramson, Mark Robinson, Carolina Gomis Perez, Ojas Chahal, Thierry Bertomeu, Andrew Chatr-aryamontri, Shalin Kothari, Kallol Gupta, Erdem Karatekin, Gang Xiao, Graeme Lancaster, Andrew Murphy, Marcus Conrad, Markus Müschen

Blood (2025) 146 (Supplement 1): 5094.

https://doi.org/10.1182/blood-2025-5094

Published: 2025

Journal Articles

Targeting immunoproteasome-dependent β-catenin degradation as a therapeutic strategy in Relapsed/Refractory acute lymphoblastic leukemia

Jodi Forward, Kadriye Nehir Cosgun, Tianhao Yin, Esma Fera, Deepa Bhojwani, David Teachey, Markus Müschen

Blood (2025) 146 (Supplement 1): 5092.

https://doi.org/10.1182/blood-2025-5092

Published: 2025

Journal Articles

Apoptotic rewiring via PI3K hyperactivation as a therapeutic strategy in B-cell malignancies

Stephen Martindale, Etienne Leveille, Jing Wang, Takeshi Ito, Kadriye Nehir Cosgun, Matthew S Davids, Markus Müschen

Blood (2025) 146 (Supplement 1): 437.

https://doi.org/10.1182/blood-2025-437

Published: 2025

Journal Articles

Targeted hyperactivation of oncogenic STAT5-signaling in acute lymphoblastic leukemia

Kohei Kume, Zhangliang Cheng, Jian Xin Lin, Liang Xu, Gang Xiao, Mark Robinson, Etienne Leveille, Eden Bramson, Kadriye Nehir Cosgun, Huimin Geng, Merja Heinäniemi, Thomas Graeber, Janis Abkowitz, Hongbo Chi, Warren Alexander, Roberto Chiarle, Warren Leonard, Markus Müschen

Blood (2025) 146 (Supplement 1): 433.

https://doi.org/10.1182/blood-2025-433

Published: 2025

Journal Articles

Lipid uptake via FATP2 enhances CAR-t therapy resistance in B-cell acute lymphoblastic leukemia

Blood (2025) 146 (Supplement 1): 325.

https://doi.org/10.1182/blood-2025-325

Published: 2025

Journal Articles

Targeting β-catenin nuclear export and protein degradation in high-risk acute lymphoblastic leukemia

Jodi Forward, Kadriye Nehir Cosgun, Esma Fera, Deepa Bhojwani, David Teachey, Markus Müschen

Blood (2025) 146 (Supplement 1): 3371.

https://doi.org/10.1182/blood-2025-3371

Published: 2025

Journal Articles

Alternating cycles of quiescent and proliferative cell states determine stemness and leukemia-initiation capacity in acute lymphoblastic leukemia

Zhangliang Cheng, Kohei Kume, Ruoyi Shi, Mark Robinson, Kadriye Nehir Cosgun, Yujin Bao, Siyi Chen, Pranav Mishra, Joerg Bewersdorf, Mina Xu, Markus Müschen

Blood (2025) 146 (Supplement 1): 1485.

https://doi.org/10.1182/blood-2025-1485

Published: 2025

Journal Articles

MYC-dependent permissiveness of PI3K hyperactivation renders metabolic vulnerability in R/R b-ALL

Junzhe Song, Huimin Liu, Xiaotian Ji, Kai Liu, Shiqi Luo, Yalin Kang, Ran Ding, Lars Klemm, Jianping Jin, Huilin Huang, Yuanhui Mao, He Huang, Markus Müschen, Gang Xiao

Blood (2025) 146 (Supplement 1): 1475.

https://doi.org/10.1182/blood-2025-1475

Published: 2025

Journal Articles

Harnessing repressive LEF1/β-catenin complexes to overcome drug resistance in chronic lymphocytic leukemia

Kadriye Nehir Cosgun, Takeshi Ito, Mark Robinson, Esma Fera, Pranav Mishra, Jodi Forward, Prajish Iyer, Lili Wang, Tiziana Vaisitti, Silvia Deaglio, Maike Buchner, Hai-Hui Xue, Matthew S Davids, Markus Müschen

Blood (2025) 146 (Supplement 1): 5659.

https://doi.org/10.1182/blood-2025-5659

Published: 2025

Journal Articles

Identification of NAE1-dependent β-catenin neddylation as selective vulnerability in B-cell malignancies

Kadriye Nehir Cosgun, Takeshi Ito, Mark Robinson, Esma Fera, Salim Oulghazi, Yanzhi Feng, Jodi Forward, Tianhao Yin, Gang Xin, Sidi Chen, Matthew S Davids, Markus Müschen

Blood (2025) 146 (Supplement 1): 5042.

https://doi.org/10.1182/blood-2025-5042

Published: 2025

Journal Articles

Stepwise leukemogenesis and therapeutic targets revealed in B-cell acute lymphoblastic leukemia driven by PAX5 mutations

Zhilian Jia, Zunsong Hu, Lu Yang, Anthony Chan, Xiaohua Huang, Allen Mao, Ibrahim Aldoss, Lucy Ghoda, Michelle Afkhami, Guido Marcucci, Zhenhua Chen, Jianjun Chen, Chun-Wei Chen, Shai Izraeli, Markus Müschen, Nora Heisterkamp, Zhaohui Gu

Blood (2025) 146 (Supplement 1): 139.

https://doi.org/10.1182/blood-2025-139

Published: 2025

Journal Articles

Inhibiting Free Fatty Acid Transport to Improve CAR-T Cell Therapy of Relapsed B-Cell Acute Lymphoblastic Leukemia

Clarissa Garcia, Kaylyn Lyons, Tian Liu, Ilaria Iacobucci, Amanda Novak, Amy Argabright, Alexis Donnelly, Julian Grandvallet Contreras, Huimin Geng, Sabrina Smith, Xin Zhou, Markus Müschen, John Edgar Dick, Julie R Haines, Angelo D'Alessandro, Charles G. Mullighan, Tzu Phang, M. Eric Kohler, Matthew Witkowski

Blood (2024) 144 (Supplement 1): 1446.

https://doi.org/10.1182/blood-2024-201015

Published: 2024

Journal Articles

Identification of High-Efficiency β-Catenin Protein Degradation As Critical Vulnerability in B-Cell Malignancies

Kadriye Nehir Cosgun, Mark E Robinson, Nikol Agadzhanian, Zhangliang Cheng, Salim Oulghazi, Philipp Berning, David Fonseca-Arce, Kohei Kume, Jake Fontaine, Lai N Chan, Jaewoong Lee, Fang Yu, Zhijian Qian, Joo Y. Song, Wing Chung Chan, Jianjun Chen, Mark M Taketo, Hilde Schjerven, Markus Müschen

Blood (2024) 144 (Supplement 1): 4125.

https://doi.org/10.1182/blood-2024-208125

Published: 2024

Journal Articles

Metabolic Determinants of Ferroptosis in B-Cell Lymphoma

Etienne Leveille, Eden Bramson, Mark E Robinson, Thierry Bertomeu, Andrew Chatr-Aryamontri, Shalin Kothari, Markus Müschen

Blood (2024) 144 (Supplement 1): 976.

https://doi.org/10.1182/blood-2024-209077

Published: 2024

Journal Articles

Cell Growth Trajectories of B-Cell Lymphomas Are Defined By Oscillations between MYC- and BCL6-Dependent States

Zhangliang Cheng, Kohei Kume, Vignesh Shanmugam, Markus Müschen

Blood (2024) 144 (Supplement 1): 45.

https://doi.org/10.1182/blood-2024-206563

Published: 2024

Journal Articles

Mechanism of Negative Feedback Regulation of Oncogenic BCR-Signaling in Mature B-Cell Lymphoma

Ruifeng Sun, Jaewoong Lee, Mark E Robinson, Kohei Kume, Chuanzong Zhan, Zhangliang Cheng, Kadriye Nehir Cosgun, Lai N Chan, Etienne Leveille, Shalin Kothari, Samuel G. Katz, Ning Ma, Vivasvan S Vykunta, Brian Shy, Daniel J Hodson, Alexander Marson, Nagarajan Vaidehi, Markus Müschen

Blood (2024) 144 (Supplement 1): 3003.

https://doi.org/10.1182/blood-2024-211693

Published: 2024

Journal Articles

PKCδ-Mediated Phosphorylation of CD25 Initiates Feedback Control of Oncogenic Tyrosine Kinases in Acute Lymphoblastic Leukemia

Ruifeng Sun, Jaewoong Lee, Dewan Artadji, Mark E Robinson, Kohei Kume, Zhangliang Cheng, Kadriye Nehir Cosgun, Lai N Chan, Etienne Leveille, Ning Ma, Huimin Geng, Elisabeth Paietta, Nagarajan Vaidehi, Markus Müschen

Blood (2024) 144 (Supplement 1): 632.

https://doi.org/10.1182/blood-2024-211038

Published: 2024

Journal Articles

Targeting β-Catenin Protein Degradation in Refractory B-Cell Malignancies

Kadriye Nehir Cosgun, Mark E Robinson, Nikol Agadzhanian, Philipp Berning, David Fonseca-Arce, Etienne Leveille, Shalin Kothari, Matthew S. Davids, Julia Jellusova, Markus Müschen

Blood (2024) 144 (Supplement 1): 1412.

https://doi.org/10.1182/blood-2024-208598

Published: 2024

Journal Articles

Identification of Nuclear NAD+ Salvage As a Therapeutic Vulnerability in B-Lymphoid Malignancies

Mark E Robinson, Qin Li, Chang Zhang, Chuanzong Zhan, Zhangliang Cheng, Kohei Kume, Kadriye Nehir Cosgun, Shalin Kothari, Nikol Agadzhanian, Daisuke Nakada, Markus Müschen

Blood (2024) 144 (Supplement 1): 4164.

https://doi.org/10.1182/blood-2024-205729

Published: 2024

Journal Articles

Development of Chimeric Antigen Receptor (CAR) T Cells Targeting MET in Lymphomas and Solid Tumors

Pohan Chen, Rianna Raghunandan, Markus Müschen, Samuel G. Katz

Blood (2023) 142 (Supplement 1): 6805.

https://doi.org/10.1182/blood-2023-186161

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Polyunsaturated fatty acids control lipid membrane dynamics and ferroptosis sensitivity in B-cell lymphoma

Targeting immunoproteasome-dependent β-catenin degradation as a therapeutic strategy in Relapsed/Refractory acute lymphoblastic leukemia

Apoptotic rewiring via PI3K hyperactivation as a therapeutic strategy in B-cell malignancies

Targeted hyperactivation of oncogenic STAT5-signaling in acute lymphoblastic leukemia

Lipid uptake via FATP2 enhances CAR-t therapy resistance in B-cell acute lymphoblastic leukemia

Targeting β-catenin nuclear export and protein degradation in high-risk acute lymphoblastic leukemia

Alternating cycles of quiescent and proliferative cell states determine stemness and leukemia-initiation capacity in acute lymphoblastic leukemia

MYC-dependent permissiveness of PI3K hyperactivation renders metabolic vulnerability in R/R b-ALL

Harnessing repressive LEF1/β-catenin complexes to overcome drug resistance in chronic lymphocytic leukemia

Identification of NAE1-dependent β-catenin neddylation as selective vulnerability in B-cell malignancies

Stepwise leukemogenesis and therapeutic targets revealed in B-cell acute lymphoblastic leukemia driven by PAX5 mutations

Inhibiting Free Fatty Acid Transport to Improve CAR-T Cell Therapy of Relapsed B-Cell Acute Lymphoblastic Leukemia

Identification of High-Efficiency β-Catenin Protein Degradation As Critical Vulnerability in B-Cell Malignancies

Metabolic Determinants of Ferroptosis in B-Cell Lymphoma

Cell Growth Trajectories of B-Cell Lymphomas Are Defined By Oscillations between MYC- and BCL6-Dependent States

Mechanism of Negative Feedback Regulation of Oncogenic BCR-Signaling in Mature B-Cell Lymphoma

PKCδ-Mediated Phosphorylation of CD25 Initiates Feedback Control of Oncogenic Tyrosine Kinases in Acute Lymphoblastic Leukemia

Targeting β-Catenin Protein Degradation in Refractory B-Cell Malignancies

Identification of Nuclear NAD+ Salvage As a Therapeutic Vulnerability in B-Lymphoid Malignancies

Development of Chimeric Antigen Receptor (CAR) T Cells Targeting MET in Lymphomas and Solid Tumors

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only